ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 1210

Epicardial Adipose Tissue and Atherosclerosis In Patients With Familial Mediterranean Fever

Adem Kucuk1, Yalcin Solak2, Hakan Akilli3, Oguzhan Yildirim3, Ibrahim Guler4, Ramazan Ucar5, Alpay Aribas3, Orhan Ozbek6, Mehmet Kayrak3 and Recep Tunc1, 1Necmettin Erbakan University, Meram Medical Faculty,Division of Rheumatology, Konya, Turkey, 2Karaman State Hospital, Division of Nephrology, Karaman, Turkey, 3Necmettin Erbakan University, Division of Cardiology, Konya, Turkey, 4Konya Research and Education Hospital, Division of Radiology, Konya, Turkey, 5Konya Education and Research Hospital, Department ofInternal Medicine, Konya, Turkey, 6Necmettin Erbakan University, Division of Radiology, Konya, Turkey

Meeting: 2013 ACR/ARHP Annual Meeting

Keywords: Atherosclerosis, familial Mediterranean fever and inflammation

  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print
Session Information

Title: Miscellaneous Rheumatic and Inflammatory Diseases I: Autoinflammatory Syndromes

Session Type: Abstract Submissions (ACR)

Background/Purpose : Familial Mediterranean Fever (FMF) is a chronic autosomal recessive hereditary disease characterized by episodic attacks of fever and inflammation of serosal and synovial membranes. Premature development of atherosclerosis has been observed in patients with chronic inflammatory diseases such as systemic lupus erythematosis and rheumatoid arthritis. The relation between epicardial adipose tissue (EAT) volume and increased inflammatory cytokines, diastolic dysfunction, myocardial ischemia and adverse clinical outcomes has been shown. We aimed to evaluate EAT as a novel marker of atherosclerosis and its relation between carotis intima media thickness (CIMT) and inflammatory markers in patients with FMF.

Methods: Seventy-nine FMF patients who had been diagnosed according to Tel-Hashomer criteria in Rheumatology outpatient clinic of a university hospital were included in the study between May 2012 and December 2012. Twenty-six age and sex matched healthy individuals were recruited as the control group. CIMT and EAT were measured and the relation between inflammatory markers were evaluated.

Results: The EAT was thicker in patients with FMF than the control group (EAT 0.47 ± 0.13 vs 0.36 ± 0.10cm, p=0.001). CIMT was also greater in patients with FMF than the control group (0.78 ± 0.2 vs 0.68 ± 0.13 mm, p=0.24). In correlation analysis, EAT was correlated with CIMT (r=0.17, p=0.1), CRP (r=0.31, p=0.005), BMI (r=0.14, p=0.16), total cholesterol (r=0.170, p=0.086), LDL (r=0.212, p=0.035) and age (r=0.188, p=0.054). CIMT was correlated with CRP (r=0.211, p=0.05), serum creatinine (r=0.224, p=0.022), total cholesterol (r=0.231, p=0.019), LDL (r=0.219, p=0.03), triglyceride (r=0.214, p=0.03), age (r=0.453, p<0.001), serum glucose (r=0.267, p=0.022) and BMI (r=0.241, p=0.013).

In multivariate linear regression model, total cholesterol level (β: 0.399, t:2.716), CRP (β: 0.150, t: 2.139) and BMI (β: 0.431, t: 2.581) were found to be independent predictors of EAT.

Conclusion: Both EAT and CIMT were significantly greater in FMF patients than control subjects. In patients with FMF, EAT may be a novel marker of increased cardiovascular risk.

Table-1. Baseline characteristic of FMF patients and control subjects

FMF Patients

Control Subjects

P value

Age (year)

38.4 ± 10

41.5 ± 9.5

0.18

BMI (kg/m2)

26.8 ± 4.9

28.1 ± 4.2

0. 20

EAT (mm)

0.47 ± 0.13

0.36 ± 0.1

0.001

CIMT (mm)

0.78 ± 0.2

0.68 ± 0.13

0.02

CRP (mg/dL)

5.5 ± 2.7

2.8 ± 1.3

<0.001

ESR (mm/h)

12.5 ± 1.4

5.2 ± 0.8

0.008

WBC (u/L)

7.5 ± 1.8

6.8 ± 1.2

0.1

Hgb (g/dL)

13.3 ± 2

14.6 ± 1.3

0.002

Creatinine (mg/dL)

0.7 ± 0.2

0.8 ± 0.1

0.29

ALT (u/L)

28 ± 17

25 ± 12

0.53

LDL (mg/dL)

111 ± 34

112 ± 28

0.87


Disclosure:

A. Kucuk,
None;

Y. Solak,
None;

H. Akilli,
None;

O. Yildirim,
None;

I. Guler,
None;

R. Ucar,
None;

A. Aribas,
None;

O. Ozbek,
None;

M. Kayrak,
None;

R. Tunc,
None.

  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print

« Back to 2013 ACR/ARHP Annual Meeting

ACR Meeting Abstracts - https://acrabstracts.org/abstract/epicardial-adipose-tissue-and-atherosclerosis-in-patients-with-familial-mediterranean-fever/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology